116 related articles for article (PubMed ID: 2547747)
21. Simplified treatment of acute lower respiratory tract infection with azithromycin: a comparison with erythromycin and amoxycillin. European Azithromycin Study Group.
Daniel R
J Int Med Res; 1991; 19(5):373-83. PubMed ID: 1660824
[TBL] [Abstract][Full Text] [Related]
22. Double-blind, comparative study of rufloxacin once daily versus amoxicillin three times a day in treatment of outpatients with exacerbations of chronic bronchitis.
Klietmann W; Cesana M; Rondel RK; Focht J
Antimicrob Agents Chemother; 1993 Nov; 37(11):2298-306. PubMed ID: 8285609
[TBL] [Abstract][Full Text] [Related]
23. Cefuroxime axetil in acute purulent exacerbations of chronic bronchitis.
Davies BI; Maesen FP; Teengs JP
Infection; 1987; 15(4):253-6. PubMed ID: 3312021
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetic and in vivo studies with azithromycin (CP-62,993), a new macrolide with an extended half-life and excellent tissue distribution.
Girard AE; Girard D; English AR; Gootz TD; Cimochowski CR; Faiella JA; Haskell SL; Retsema JA
Antimicrob Agents Chemother; 1987 Dec; 31(12):1948-54. PubMed ID: 2830841
[TBL] [Abstract][Full Text] [Related]
25. Five-day dirithromycin therapy is as effective as seven-day erythromycin therapy for acute exacerbations of chronic bronchitis.
Wasilewski MM; Johns D; Sides GD
J Antimicrob Chemother; 1999 Apr; 43(4):541-8. PubMed ID: 10350384
[TBL] [Abstract][Full Text] [Related]
26. Long-term, low-dose azithromycin treatment reduces the incidence but increases macrolide resistance in Staphylococcus aureus in Danish CF patients.
Hansen CR; Pressler T; Hoiby N; Johansen HK
J Cyst Fibros; 2009 Jan; 8(1):58-62. PubMed ID: 18849202
[TBL] [Abstract][Full Text] [Related]
27. Amoxycillin/clavulanate in acute purulent exacerbations of chronic bronchitis.
Maesen FP; Davies BI; Baur C
J Antimicrob Chemother; 1987 Mar; 19(3):373-83. PubMed ID: 3494724
[TBL] [Abstract][Full Text] [Related]
28. Erythromycin succinate in the treatment of acute exacerbations of chronic bronchitis.
Beumer HM; Dubourg AY; Soetens A
Eur J Clin Pharmacol; 1978 Mar; 13(1):25-7. PubMed ID: 346354
[TBL] [Abstract][Full Text] [Related]
29. Serum and sputum concentrations of enoxacin after single oral dosing in a clinical and bacteriological study.
Davies BI; Maesen FP; Teengs JP
J Antimicrob Chemother; 1984 Sep; 14 Suppl C():83-9. PubMed ID: 6594325
[TBL] [Abstract][Full Text] [Related]
30. The safety and efficacy of short course (5-day) moxifloxacin vs. azithromycin in the treatment of patients with acute exacerbation of chronic bronchitis.
DeAbate CA; Mathew CP; Warner JH; Heyd A; Church D
Respir Med; 2000 Nov; 94(11):1029-37. PubMed ID: 11127487
[TBL] [Abstract][Full Text] [Related]
31. Azithromycin for acute lower respiratory tract infections.
Panpanich R; Lerttrakarnnon P; Laopaiboon M
Cochrane Database Syst Rev; 2004 Oct; (4):CD001954. PubMed ID: 15497172
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and tolerability of azithromycin versus amoxicillin/clavulanic acid in acute purulent exacerbation of chronic bronchitis.
Beghi G; Berni F; Carratù L; Casalini A; Consigli G; D'Antò M; Gioia V; Molino A; Paizis G; Vaghi A
J Chemother; 1995 Apr; 7(2):146-52. PubMed ID: 7666122
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of 3-day azithromycin versus 5-day moxifloxacin for the treatment of acute bacterial exacerbations of chronic bronchitis.
Zervos M; Martinez FJ; Amsden GW; Rothermel CD; Treadway G
Int J Antimicrob Agents; 2007 Jan; 29(1):56-61. PubMed ID: 17189096
[TBL] [Abstract][Full Text] [Related]
34. Clinical, bacteriological and pharmacokinetic results from an open trial of sultamicillin in patients with acute exacerbations of chronic bronchitis.
Davies BI; Maesen FP; van Noord JA
J Antimicrob Chemother; 1984 Feb; 13(2):161-70. PubMed ID: 6323377
[TBL] [Abstract][Full Text] [Related]
35. Doxycycline and minocycline in the treatment of respiratory infections: a double-blind comparative clinical, microbiological and pharmacokinetic study.
Maesen FP; Davies BI; van den Bergh JJ
J Antimicrob Chemother; 1989 Jan; 23(1):123-9. PubMed ID: 2501265
[TBL] [Abstract][Full Text] [Related]
36. Pulmonary penetration of dirithromycin in patients suffering from acute exacerbation of chronic bronchitis.
Cazzola M; Matera MG; Tufano MA; Polverino M; Catalanotti P; Varanese L; Rossi F
Pulm Pharmacol; 1994 Dec; 7(6):377-81. PubMed ID: 7549225
[TBL] [Abstract][Full Text] [Related]
37. Clinical efficacy of azithromycin in lower respiratory tract infections.
Morandini G; Perduca M; Zannini G; Foschino MP; Miragliotta G; Carnimeo NS
J Chemother; 1993 Feb; 5(1):32-6. PubMed ID: 8384658
[TBL] [Abstract][Full Text] [Related]
38. Cefodizime and cefotaxime in acute exacerbations of chronic bronchitis: a randomized double-blind prospective study in 180 patients.
Maesen FP; Davies BI; van den Bergh JJ; Gubbelmans HL; Meek JC; Geraedts WH
J Antimicrob Chemother; 1990 Mar; 25(3):413-22. PubMed ID: 2187013
[TBL] [Abstract][Full Text] [Related]
39. Clarithromycin in the treatment of bacterial relapses of chronic bronchitis.
Dericoloso A; Sanduzzi A; Cuccurullo S; Sarno M; Bianco A; Moro RA
Riv Eur Sci Med Farmacol; 1991; 13(5-6):275-83. PubMed ID: 1840282
[TBL] [Abstract][Full Text] [Related]
40. Infective exacerbations of chronic bronchitis: relation between bacteriologic etiology and lung function.
Eller J; Ede A; Schaberg T; Niederman MS; Mauch H; Lode H
Chest; 1998 Jun; 113(6):1542-8. PubMed ID: 9631791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
